KROS
Keros Therapeutics, Inc.
+0.27 (+2.51%)11.01USD93.5K成交股數218M市值–本益比(近四季)14.5股價營收比-100.0%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 367K-100% | 385K-1% | 14.3M+38446% | 18.2M+21789% | 211M+147624% | 388K+4750% | 37K | 83K | 143K | 8K | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 22.3M | 16.1M | 17.9M | 19.5M | 43.5M | 48.7M | 49.2M | 40.5M | 38.3M | 37.5M | 34.1M | 32.5M |
| 銷售管理費用 | 8.6M | 10.1M | 11.7M | 10.1M | 14.5M | 10.5M | 9.8M | 10.0M | 10.3M | 9.1M | 9.1M | 8.8M |
| 營業利益 | −30.9M-22% | −25.9M-117% | −29.3M-50% | −15.4M-69% | −39.8M-18% | 152M-427% | −58.7M+36% | −50.4M+22% | −48.5M | −46.5M | −43.3M | −41.3M |
| 營業利益率 | – | -7,051.0% | -7,602.6% | -107.9% | -219.2% | 72.0% | -15,117.8% | -136,321.6% | -58,413.3% | -32,486.0% | -541,000.0% | – |
| 稅後淨利 | −28.7M-6% | −23.7M-116% | −23.5M-56% | −7.3M-84% | −30.7M-29% | 148M-469% | −53.0M+34% | −45.3M+21% | −43.1M | −40.2M | −39.4M | −37.5M |
| 淨利率 | – | -6,459.9% | -6,093.8% | -51.0% | -169.0% | 70.3% | -13,648.5% | -122,316.2% | -51,944.6% | -28,142.0% | -493,000.0% | – |
| 稀釋 EPS | -1.45+91% | -1.21-133% | -0.38-73% | -0.18-86% | -0.76-37% | 3.62-370% | -1.41+6% | -1.25-2% | -1.21 | -1.34 | -1.33 | -1.27 |
| 稀釋股數 | 19.8M | 19.6M | 37.9M | 40.6M | 40.6M | 41.0M | 37.6M | 36.1M | 35.7M | 29.4M | 29.7M | 29.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 258M | 281M | 287M | 693M | 690M | 721M | 531M | 406M | 442M | 331M | 288M | 322M |
| 應收帳款 | 0.00 | 400K | 3.6M | 3.5M | 15.8M | 17.3M | 388K | 4K | 226K | 143K | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 288M | 312M | 338M | 743M | 757M | 785M | 579M | 455M | 486M | 370M | 326M | 356M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 25.3M | 26.7M | 34.9M | 39.2M | 50.4M | 55.7M | 46.4M | 34.1M | 31.9M | 37.8M | 30.4M | 30.0M |
| 股東權益 | 262M | 286M | 303M | 704M | 707M | 729M | 533M | 421M | 454M | 332M | 296M | 326M |
| 負債比 | 8.8% | 8.5% | 10.3% | 5.3% | 6.7% | 7.1% | 8.0% | 7.5% | 6.6% | 10.2% | 9.3% | 8.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.5M-102% | – | – | – | 161M | – | – | −44.6M | – | – | – |
| 資本支出 | – | 73K | – | – | – | 565K | – | – | 946K | – | – | – |
| 自由現金流 | – | −3.6M-102% | – | – | – | 161M | – | – | −45.5M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -981.5% | – | – | – | 76.0% | – | – | -54,826.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 244M
| Reportable | 244M | 100.0% | +6775.0% |
|---|
產品／服務2025 年度 · 283M
| License | 205M | 72.7% | +6745.2% |
|---|---|---|---|
| Service Other | 38.7M | 13.7% | +6937.5% |
| 服務 | 38.5M | 13.6% | +1183.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 244M | +6775.0% | 87.0M | 35.7% | 2.30 | 106M |
| FY2024 | 3.6M | +2251.0% | −187M | -5,277.5% | -5.00 | −163M |
| FY2023 | 151K | – | −153M | -101,319.2% | -5.20 | −127M |
| FY2022 | 0.00 | -100.0% | −105M | –% | -4.15 | −71.3M |
| FY2021 | 20.1M | – | −58.7M | -292.3% | -2.52 | −63.2M |
| FY2020 | 0.00 | -100.0% | −45.4M | –% | -2.93 | −37.2M |
| FY2019 | 10.0M | – | −12.3M | -123.4% | -6.08 | −16.3M |